ERBB2 and neoplasm: The oncogenic mechanisms of HER2 include inhibiting tumor cell apoptosis, increasing tumor cell invasiveness, promoting tumor cell proliferation, and promoting tumor angiogenesis and lymphangiogenesis (18).